MISSISSAUGA, Ontario, Nov. 23, 2010 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (TSX: VRX) today announced members of its senior management team will make a presentation at the Piper Jaffray 22nd Annual Health Care Conference on Wednesday, December 1, 2010 at 1:30 p.m. ET. The conference will be held at the New York Palace in New York, NY.
A live webcast and audio archive of the presentation will be available on the company's website at http://www.valeant.com/. Click on Investor Relations, and then the link to Events and Presentations. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. The webcast can also be accessed through the following URL: http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=VRX&item_id=3497386
About Valeant
Valeant Pharmaceuticals International, Inc. (TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. More information about Valeant can be found at http://www.valeant.com/.
Contact Information: Laurie W. Little 949-461-6002 laurie.little@valeant.com (Logo: http://photos.prnewswire.com/prnh/20101025/LA87217LOGO)
PRN Photo Desk, photodesk@prnewswire.com
Valeant Pharmaceuticals International, Inc.
CONTACT: Laurie W. Little of Valeant Pharmaceuticals International,
Inc., +1-949-461-6002, laurie.little@valeant.com
Web Site: http://www.valeant.com/
